Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology

Neutropenia Clinical Trials

A listing of Neutropenia medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 Last 

Arizona

Arizona Center for Cancer Care
Glendale Arizona 85306
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

California

Innovative Clinical Research Institute
Burbank California 91505
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

California Cancer Associates for Research and Excellence
Fresno California 93720
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Beaver Medical Group
Highland California 92346
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

California Cancer Associates for Research and Excellence
Los Angeles California 92025
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

North County Oncology
Oceanside California 92056
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

View More »

Hematology Oncology Medical Group
Orange California 92868
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Comprehensive Cancer Center at Desert Regional Medical Center
Palm Springs California 92262
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Sarcoma Oncology
Santa Monica California 90403
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Innovative Clinical Research Institute
Whittier California 90603
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Florida

University Cancer Institute
Boynton Beach Florida 33426
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Research- Hen/Onc Associates of the Treasure Coast
Port St. Lucie Florida 34952

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Georgia

Northeast Georgia Cancer Care, LLC
Athens Georgia 30607
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Illinois

Edward H. Kaplan MD & Associates
Skokie Illinois 60076
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Kentucky

Kentucky Cancer Clinic
Hazard Kentucky 41701
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda Maryland 20892

Patients are needed to participate in a clinical research study of Clofarabine and Lenalidomide

Missouri

Saint Louis University
St. Louis Missouri 63110
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

New York

New York Oncology Hematology, PC
Albany New York 12206
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Memorial Sloan-Kettering Cancer Center
New York New York 10065

A Phase 4 clinical study for patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

University of Rochester Medical Center
Rochester New York 14642

A Phase 3 clinical study for patients with Febrile Neutropenia

North Shore Hematology/Oncology Associates
Setauket New York 11733
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Ohio

The Mark H. Zangmeister Center
Columbus Ohio 43219
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Oregon

Good Samaritan Hospital, Corvallis
Corvallis Oregon 97330
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Tennessee

Associates in Oncology & Hematology
Chattanooga Tennessee 37421

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Texas

The University of Texas, Health Science Center at San Antonio
San Antonio Texas 78229

Patients are needed to participate in a clinical research study of PledOx (2 µmol/kg), PledOx (10 µmol/kg) and Placebo (0,9% NaCl) to evaluate Advanced Metastatic (Stage IV) Colorectal Cancer

Australia

Frankston Hospital
Frankston Victoria 3199
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Ashford Cancer Center Research
Kurralta Park 5037
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Box Hill Hospital
Melbourne Victoria 3128
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

St Vincent's Hospital
Melbourne Victoria 3065
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

St Vincent's Hospital
Melbourne 3065
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

View More »

Breast Cancer Research Center, WA
Perth 6000
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Royal Hobart
Tasmania 7000
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Ballarat Oncology & Haematology
Wendouree 3355
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Canada

Cross Cancer Institute
Edmonton Alberta T6G1Z2
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

China

Cancer Institute and Hospital, CAMS
Beijing

A clinical research study of pegfilgrastim,30mcg/kg, pegfilgrastim, 60mcg/kg, pegfilgrastim, 100mcg/kg and filgrastim, 5mcg/kg for the treatment of Neutropenia

Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing Beijing 100021

Patients are needed to participate in a clinical research study evaluating Pegfilgrastim for the treatment of Neutropenia

Beijing Cancer Hospital
Beijing 100142

Patients are needed to participate in a clinical research study of rHSA/GCSF to evaluate Underdose (Unintentional), Cancer or Tumor

Cancer Institute and Hospital, CAMS
Beijing

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy for the treatment of Non Small Cell Lung Cancer or Breast Cancer

Shanghai Pulmonary Hospital
Shanghai Shanghai 200433

A Phase 3 clinical study for patients with NSCLC, Neutropenia or Febrile Neutropenia

Czech Republic

Regional Hospital
Mladá Boleslav 293 50
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Nemocnice Znojmo
Znojmo 66902

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

France

Hôpital Européen Georges Pompidou - Service Oncologie Médicale
Paris 75908

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

Georgia

LTD " Cancer Center of Adjara Autonomic Republic"
Batumi 6000
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Ltd ` Medulla - Chemotherapy and Immunotherapy Clinic
Tbilisi 0186
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Ltd " High Technology Medical Center University Clinic"
Tbilisi 0144
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

JSC " Neo Medi"
Tbilisi 0131
Updated

Patients are needed to participate in a clinical research study evaluating HM10460A (45 μg/kg), HM10460A (135 μg/kg), HM10460A (270 μg/kg) and Pegfilgrastim 6mg for the treatment of Neutropenia

Germany

Teva Investigational Site 32277
Berlin

Patients are needed to participate in a clinical research study evaluating lipegfilgrastim and pegfilgrastim for the treatment of Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

University Hospital Cologne
Cologne NRW 50937

A clinical research study of 3M Tegaderm IV securement dressing for the treatment of Catheter-related Bloodstream Infection

Universitaetsklinik Hamburg-Eppendorf, Med. Klinik II Onkologie, Haematologie
Hamburg 20246

Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor

MHH
Hannover

A clinical research study of Eligible patients will be treated with Zarzio for the treatment of Severe Chronic Neutropenia

First 1 2 Last